3rd Quarter - Report

B. BRAUN MEDICAL for B. BRAUN MEDICAL

Firm
Client
Income
—
Expenses
$116,500
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Consumer Issues/Safety/Products CSP

FDA issues drug and device shortages

LobbyistCovered position, as disclosed
ALICIA KERRY MICA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

generic pharmaceutical and medical device issues

LobbyistCovered position, as disclosed
ALICIA KERRY MICA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Tariff (miscellaneous tariff bills) TAR

drug and device shortage issues

LobbyistCovered position, as disclosed
ALICIA KERRY MICA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR); Commerce, Dept of (DOC)

Pharmacy PHA

drug quality security act, 503A and 503B pharmacy issues

LobbyistCovered position, as disclosed
ALICIA KERRY MICA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.